日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Calprotectin, a Promising Serological Biomarker for the Early Diagnosis of Superinfections with Multidrug-Resistant Bacteria in Patients with COVID-19

钙卫蛋白:一种有前景的血清学生物标志物,可用于早期诊断新冠肺炎患者合并多重耐药菌感染

Keller, Dennis; Mester, Patricia; Räth, Ulrich; Krautbauer, Sabrina; Schmid, Stephan; Greifenberg, Verena; Müller, Martina; Kunst, Claudia; Buechler, Christa; Pavel, Vlad

Moving Back to the Parental Home in Times of COVID-19: Consequences for Students' Life Satisfaction

新冠疫情期间搬回父母家:对学生生活满意度的影响

Preetz, Richard; Greifenberg, Julius; Hülsemann, Julika; Filser, Andreas

Structure-activity relationship study of THZ531 derivatives enables the discovery of BSJ-01-175 as a dual CDK12/13 covalent inhibitor with efficacy in Ewing sarcoma

THZ531衍生物的构效关系研究发现了BSJ-01-175,它是一种对尤文氏肉瘤有效的双重CDK12/13共价抑制剂。

Jiang, Baishan; Jiang, Jie; Kaltheuner, Ines H; Iniguez, Amanda Balboni; Anand, Kanchan; Ferguson, Fleur M; Ficarro, Scott B; Seong, Bo Kyung Alex; Greifenberg, Ann Katrin; Dust, Sofia; Kwiatkowski, Nicholas P; Marto, Jarrod A; Stegmaier, Kimberly; Zhang, Tinghu; Geyer, Matthias; Gray, Nathanael S

Effect of Bacillus clausii Capsules in Reducing Adverse Effects Associated with Helicobacter pylori Eradication Therapy: A Randomized, Double-Blind, Controlled Trial

枯草芽孢杆菌胶囊在减少幽门螺杆菌根除治疗相关不良反应中的作用:一项随机、双盲、对照试验

Plomer, Manuel; Iii Perez, Marcos; Greifenberg, Dorothea Maren

Correction to: Effect of Bacillus clausii Capsules in Reducing Adverse Effects Associated with Helicobacter pylori Eradication Therapy: A Randomized, Double-Blind, Controlled Trial

更正:枯草芽孢杆菌胶囊在减少幽门螺杆菌根除疗法相关不良反应中的作用:一项随机、双盲、对照试验

Plomer, Manuel; Perez, Marcos Iii; Greifenberg, Dorothea Maren

[Antibiotic stewardship (ABS)-strategies for urologists in private practice and hospitals]

[抗菌药物管理(ABS)——泌尿科医生在私人诊所和医院的策略]

Lichtinger, U; Greifenberg, V; Gessner, A

MIR sequences recruit zinc finger protein ZNF768 to expressed genes

MIR 序列募集锌指蛋白 ZNF768 到表达基因

Michaela Rohrmoser, Michael Kluge, Yousra Yahia, Anita Gruber-Eber, Muhammad Ahmad Maqbool, Ignasi Forné, Stefan Krebs, Helmut Blum, Ann Katrin Greifenberg, Matthias Geyer, Nicolas Descostes, Axel Imhof, Jean-Christophe Andrau, Caroline C Friedel, Dirk Eick

Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors

共价靶向远端半胱氨酸残基以开发 CDK12 和 CDK13 抑制剂

Tinghu Zhang, Nicholas Kwiatkowski, Calla M Olson, Sarah E Dixon-Clarke, Brian J Abraham, Ann K Greifenberg, Scott B Ficarro, Jonathan M Elkins, Yanke Liang, Nancy M Hannett, Theresa Manz, Mingfeng Hao, Bartlomiej Bartkowiak, Arno L Greenleaf, Jarrod A Marto, Matthias Geyer, Alex N Bullock, Richard

CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer

CDK12 抑制可逆转 BRCA 野生型和突变型三阴性乳腺癌模型中的新生和获得性 PARP 抑制剂耐药性

Shawn F Johnson, Cristina Cruz, Ann Katrin Greifenberg, Sofia Dust, Daniel G Stover, David Chi, Benjamin Primack, Shiliang Cao, Andrea J Bernhardy, Rhiannon Coulson, Jean-Bernard Lazaro, Bose Kochupurakkal, Heather Sun, Christine Unitt, Lisa A Moreau, Kristopher A Sarosiek, Maurizio Scaltriti, Dejan

P-TEFb regulation of transcription termination factor Xrn2 revealed by a chemical genetic screen for Cdk9 substrates

Cdk9 底物的化学遗传筛选揭示了 P-TEFb 对转录终止因子 Xrn2 的调节

Miriam Sansó, Rebecca S Levin, Jesse J Lipp, Vivien Ya-Fan Wang, Ann Katrin Greifenberg, Elizabeth M Quezada, Akbar Ali, Animesh Ghosh, Stéphane Larochelle, Tariq M Rana, Matthias Geyer, Liang Tong, Kevan M Shokat, Robert P Fisher